Covered recipient · General Payments record
JESSICA HARMS
Allopathic & Osteopathic Physicians Dermatology
General Payments · PY2019–2024
$526.15
- Reported across 15 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $229.02 | 12 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Incyte Corporation | $97.20 | 5 |
| GENZYME CORPORATION | $37.36 | 2 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $22.37 | 1 |
| Regeneron Healthcare Solutions, Inc. | $20.98 | 1 |
| Lilly USA, LLC | $18.35 | 1 |
| ABBVIE INC. | $16.39 | 1 |
| Galderma Laboratories, L.P. | $16.37 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (12)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $16.39 | 08/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103880860 | CMS |
| Galderma Laboratories, L.P. | $16.37 | 10/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145302715 | CMS |
| GENZYME CORPORATION | $19.02 | 11/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139911927 | CMS |
| GENZYME CORPORATION | $18.34 | 12/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139911947 | CMS |
| Incyte Corporation | $19.97 | 02/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141270292 | CMS |
| Incyte Corporation | $18.87 | 04/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141242224 | CMS |
| Incyte Corporation | $14.72 | 06/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141225004 | CMS |
| Incyte Corporation | $15.91 | 10/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141302463 | CMS |
| Incyte Corporation | $27.73 | 10/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141302793 | CMS |
| Lilly USA, LLC | $18.35 | 05/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135045306 | CMS |
| Novartis Pharmaceuticals Corporation | $22.37 | 08/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1086949007 | CMS |
| Regeneron Healthcare Solutions, Inc. | $20.98 | 11/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114065486 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2019, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2019 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.